---
pmid: '22764206'
title: Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells
  from patients with familial Parkinson's disease.
authors:
- Cooper O
- Seo H
- Andrabi S
- Guardia-Laguarta C
- Graziotto J
- Sundberg M
- McLean JR
- Carrillo-Reid L
- Xie Z
- Osborn T
- Hargus G
- Deleidi M
- Lawson T
- Bogetofte H
- Perez-Torres E
- Clark L
- Moskowitz C
- Mazzulli J
- Chen L
- Volpicelli-Daley L
- Romero N
- Jiang H
- Uitti RJ
- Huang Z
- Opala G
- Scarffe LA
- Dawson VL
- Klein C
- Feng J
- Ross OA
- Trojanowski JQ
- Lee VM
- Marder K
- Surmeier DJ
- Wszolek ZK
- Przedborski S
- Krainc D
- Dawson TM
- Isacson O
journal: Sci Transl Med
year: '2012'
full_text_available: false
pmcid: PMC3462009
doi: 10.1126/scitranslmed.3003985
---

# Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.
**Authors:** Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L, Xie Z, Osborn T, Hargus G, Deleidi M, Lawson T, Bogetofte H, Perez-Torres E, Clark L, Moskowitz C, Mazzulli J, Chen L, Volpicelli-Daley L, Romero N, Jiang H, Uitti RJ, Huang Z, Opala G, Scarffe LA, Dawson VL, Klein C, Feng J, Ross OA, Trojanowski JQ, Lee VM, Marder K, Surmeier DJ, Wszolek ZK, Przedborski S, Krainc D, Dawson TM, Isacson O
**Journal:** Sci Transl Med (2012)
**DOI:** [10.1126/scitranslmed.3003985](https://doi.org/10.1126/scitranslmed.3003985)
**PMC:** [PMC3462009](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462009/)

## Abstract

1. Sci Transl Med. 2012 Jul 4;4(141):141ra90. doi: 10.1126/scitranslmed.3003985.

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells 
from patients with familial Parkinson's disease.

Cooper O(1), Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, 
McLean JR, Carrillo-Reid L, Xie Z, Osborn T, Hargus G, Deleidi M, Lawson T, 
Bogetofte H, Perez-Torres E, Clark L, Moskowitz C, Mazzulli J, Chen L, 
Volpicelli-Daley L, Romero N, Jiang H, Uitti RJ, Huang Z, Opala G, Scarffe LA, 
Dawson VL, Klein C, Feng J, Ross OA, Trojanowski JQ, Lee VM, Marder K, Surmeier 
DJ, Wszolek ZK, Przedborski S, Krainc D, Dawson TM, Isacson O.

Author information:
(1)Neuroregeneration Institute, McLean Hospital/Harvard Medical School, Belmont, 
MA 02478, USA.

Parkinson's disease (PD) is a common neurodegenerative disorder caused by 
genetic and environmental factors that results in degeneration of the 
nigrostriatal dopaminergic pathway in the brain. We analyzed neural cells 
generated from induced pluripotent stem cells (iPSCs) derived from PD patients 
and presymptomatic individuals carrying mutations in the PINK1 (PTEN-induced 
putative kinase 1) and LRRK2 (leucine-rich repeat kinase 2) genes, and compared 
them to those of healthy control subjects. We measured several aspects of 
mitochondrial responses in the iPSC-derived neural cells including production of 
reactive oxygen species, mitochondrial respiration, proton leakage, and 
intraneuronal movement of mitochondria. Cellular vulnerability associated with 
mitochondrial dysfunction in iPSC-derived neural cells from familial PD patients 
and at-risk individuals could be rescued with coenzyme Q(10), rapamycin, or the 
LRRK2 kinase inhibitor GW5074. Analysis of mitochondrial responses in 
iPSC-derived neural cells from PD patients carrying different mutations provides 
insight into convergence of cellular disease mechanisms between different 
familial forms of PD and highlights the importance of oxidative stress and 
mitochondrial dysfunction in this neurodegenerative disease.

DOI: 10.1126/scitranslmed.3003985
PMCID: PMC3462009
PMID: 22764206 [Indexed for MEDLINE]
